Neena Bitritto-Garg
Stock Analyst at Deutsche Bank
Total Price Targets
4
Stocks Covered
4
Sectors
Healthcare
Most Recent
Apr 4, 2024
Stocks Covered by Neena Bitritto-Garg
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.00 | $16.04 | -75.1% | 1 | Apr 4, 2024 |
| ROIV | Roivant Sciences Ltd. | $15.00 | $28.06 | -46.5% | 1 | Apr 3, 2024 |
| ACAD | ACADIA Pharmaceuticals Inc. | $32.00 | $21.95 | +45.8% | 1 | Mar 1, 2022 |
| NBIX | Neurocrine Biosciences, Inc. | $129.00 | $131.64 | -2.0% | 1 | Dec 8, 2021 |
Recent Activity
Frequently Asked Questions
Who is Neena Bitritto-Garg?
Neena Bitritto-Garg is a stock analyst at Deutsche Bank covering 4 stocks primarily in Healthcare. They have issued 4 price targets since Dec 8, 2021.
What stocks does Neena Bitritto-Garg cover?
Neena Bitritto-Garg currently covers 4 stocks, including AMLX, ROIV, ACAD, NBIX.
What is Neena Bitritto-Garg's latest price target?
Neena Bitritto-Garg's most recent price target was $4.00 on AMLX (Amylyx Pharmaceuticals, Inc.), set on Apr 4, 2024.
What is Neena Bitritto-Garg's highest price target?
Neena Bitritto-Garg's highest issued price target is $129.00 on NBIX, set on Dec 8, 2021.
More Analysts at Deutsche Bank
Coverage based on publicly published price targets. Not investment advice.